As of 2025-08-27, the Relative Valuation of Global Blood Therapeutics Inc (GBT) is (99.40) USD. This relative valuation is based on P/E multiples. With the latest stock price at 68.49 USD, the upside of Global Blood Therapeutics Inc based on Relative Valuation is -245.1%.
The range of the Relative Valuation is (83.92) - (103.42) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.1x - 21.6x | 18.8x |
| Forward P/E multiples | 17.6x - 27.9x | 22.8x |
| Fair Price | (83.92) - (103.42) | (99.40) |
| Upside | -222.5% - -251.0% | -245.1% |
| Date | P/E |